Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole - Wikidata - wikimedia - TriplyDB

Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole

Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole

http://www.wikidata.org/entity/Q34661581

about

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression Inflammation Models of Depression in Rodents: Relevance to Psychotropic Drug Discovery Review of pharmacological treatment in mood disorders and future directions for drug development.The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission A review of MR spectroscopy studies of pediatric bipolar disorder A critical review of magnetic resonance spectroscopy studies of obsessive-compulsive disorder Emergent treatments based on the pathophysiology of bipolar disorder: A selective review Two-dimensional J-resolved proton MR spectroscopy and prior knowledge fitting (ProFit) in the frontal and parietal lobes of healthy volunteers: assessment of metabolite discrimination and general reproducibility.Coculture of Primary Motor Neurons and Schwann Cells as a Model for In Vitro Myelination.Glutamate and glutamine: a review of in vivo MRS in the human brain Chronic SSRI stimulation of astrocytic 5-HT2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift.Inflammation: opportunities for treatment stratification among individuals diagnosed with mood disorders.Glutamatergic and resting-state functional connectivity correlates of severity in major depression - the role of pregenual anterior cingulate cortex and anterior insula Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approach Proof of concept trials in bipolar disorder and major depressive disorder: a translational perspective in the search for improved treatments.Glutamatergic regulation prevents hippocampal-dependent age-related cognitive decline through dendritic spine clustering.Relationship between genetic variation in the glutaminase gene GLS1 and brain glutamine/glutamate ratio measured in vivo Frontal P3 event-related potential is related to brain glutamine/glutamate ratio measured in vivo.Lamotrigine blocks NMDA receptor-initiated arachidonic acid signalling in rat brain: implications for its efficacy in bipolar disorder Novel glutamatergic agents for major depressive disorder and bipolar disorder.RETRACTED: Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients.Brain and cognition abnormalities in long-term anabolic-androgenic steroid users.Reduced density of glutamine synthetase immunoreactive astrocytes in different cortical areas in major depression but not in bipolar I disorder Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot randomized placebo-controlled trial.Frontal lobe bioenergetic metabolism in depressed adolescents with bipolar disorder: a phosphorus-31 magnetic resonance spectroscopy study N-acetylaspartate normalization in bipolar depression after lamotrigine treatment A pilot study of hippocampal volume and N-acetylaspartate (NAA) as response biomarkers in riluzole-treated patients with GAD.Riluzole effect on occipital cortex: a structural and spectroscopy pilot study.Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depression A placebo-controlled trial of acetyl-L-carnitine and α-lipoic acid in the treatment of bipolar depression Transcranial magnetic stimulation potentiates glutamatergic neurotransmission in depressed adolescents.Multi-locus genome-wide association analysis supports the role of glutamatergic synaptic transmission in the etiology of major depressive disorder.Hippocampal abnormalities of glutamate/glutamine, N-acetylaspartate and choline in patients with depression are related to past illness burden An Examination of Rostral Anterior Cingulate Cortex Function and Neurochemistry in Obsessive-Compulsive Disorder.From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders Main Effects of Diagnoses, Brain Regions, and their Interaction Effects for Cerebral Metabolites in Bipolar and Unipolar Depressive Disorders.Ketamine as antidepressant? Current state and future perspectives.Neural correlates of rapid antidepressant response to ketamine in bipolar disorder.New drugs for bipolar disorder.

P2860

Q24630153-F9EA4600-3366-49A0-9083-E55EF7652282 Q26749497-33698F6C-2B0E-4CE1-B879-D921D7C18BC6 Q26853509-948961D3-0BDF-4F0C-9055-C9C1D54EEEB8 Q26859198-888845C8-FA75-4AF6-A7B4-62C68E23CFCD Q26991430-91D07DB4-213A-472F-9FBD-D25C578983A2 Q27025872-59F7EBE0-AA00-4EE7-9661-E90610553E98 Q28082445-054E56AC-51FB-49B4-ABA4-CA17A9C24795 Q30572951-D9A885C7-19E2-4CD1-8976-25AB846E7D6B Q30667587-BF1F74DC-80BB-4937-9F07-F2C960DA0C5B Q30677120-FAF33887-2853-4889-B0AA-749F2C54A156 Q30906677-4A9FC780-CA80-4424-9D0F-A1E7DA864B45 Q33721019-6185FE37-CB07-4C5F-9F25-C1775CD529CF Q34038694-9C06D07A-9252-4B31-836E-D76A3B99B635 Q34204211-640AB9A0-D53A-4DC5-B198-F5C2CEE35AA9 Q34268501-BD3EE712-AC94-4AB2-A4AA-719954CA1825 Q34766451-778EF13D-E045-4D44-B759-513AE3330B24 Q34831048-FD2774D8-AAD6-43ED-9106-FCD559130DA2 Q35074537-5D34EBF4-9BC9-412A-84B6-EF3D1EB041C4 Q35374474-A2C9D7A7-F4E0-4EF4-9EC9-6D5B325DB650 Q35476477-AEE84E4F-01DC-4851-BE04-63F122AC7B28 Q35661119-69AC7482-5299-4823-82D4-A7F3D5DFD070 Q35662070-2E5C1F82-7A05-4BE5-833C-3002EC5E211C Q35690343-1894929A-2B1A-42BA-B0C6-5068E82B4985 Q35933481-0E33A290-4EAE-43C7-B32F-36C377F6B284 Q36029739-E3DF8E74-A92E-4FB9-B9EE-A3F0E312951B Q36295874-9F62B642-2FB7-4F78-BB15-27B9EEAAAFD7 Q36306253-B7EE39E6-F25B-4B70-A181-CAAA6D55D953 Q36323051-29B689ED-6CFD-42FF-8F65-39F44D011F4C Q36374329-2801A461-88E6-445D-BD52-D42EED58DA70 Q36417179-F9ACC95E-BBEC-42F7-B5C2-FD8D6BFB1AC9 Q36424640-14090A21-7705-45D1-915D-EFD6E84ECA0A Q36474017-D5A92B7F-1EF9-4719-A442-6DD4A544938E Q36591241-E7EFF360-D090-4B3B-B20F-528A15FA3892 Q36636309-37106C33-8BF6-43A6-ADA7-C4C7EAF756C0 Q36821758-BE3D969E-DA0B-4CA7-B92B-A47771453259 Q36944201-C5FB9D78-E731-4657-A3BB-DD2A020BD104 Q37425085-50E30B6B-2A97-4E44-B2B7-864235566D01 Q37559823-31D190A2-C576-44C0-A735-15C5399E13BE Q37629424-E60F7270-2129-4F11-A40C-EBCC9B7CA50E Q37923845-9EC6B918-319E-4B48-9800-5F1DC5A7204B

P2860

Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole

http://www.wikidata.org/entity/Q34661581

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Rapid enhancement of glutamate ...... lowing treatment with riluzole

@ast

Rapid enhancement of glutamate ...... lowing treatment with riluzole

@en

Rapid enhancement of glutamate ...... lowing treatment with riluzole

@nl

type

label

Rapid enhancement of glutamate ...... lowing treatment with riluzole

@ast

Rapid enhancement of glutamate ...... lowing treatment with riluzole

@en

Rapid enhancement of glutamate ...... lowing treatment with riluzole

@nl

prefLabel

Rapid enhancement of glutamate ...... lowing treatment with riluzole

@ast

Rapid enhancement of glutamate ...... lowing treatment with riluzole

@en

Rapid enhancement of glutamate ...... lowing treatment with riluzole

@nl

P1433

Q34661581-4A8E33FC-BAFE-4F22-9C9E-1B5054333651

P1476

Q34661581-09F23F6E-9F92-4BFF-91EA-151443F4934F

P2093

Q34661581-32E2E8EA-5676-41F7-8D3C-AC94E97E72DC

Q34661581-3FFD528F-7EF1-4AB1-B7D6-AEC5C9D28390

Q34661581-4847B854-5CDB-44EC-9847-1148C5B9FC76

Q34661581-80391B53-8764-4872-B67A-EF3271FACF87

Q34661581-880CA4D0-1E12-4F85-9A6B-25DA68567B25

Q34661581-BF6EC9FD-49BF-416B-904A-BF6ED552231A

Q34661581-C7DCA317-5A6C-4683-8306-368C7E676708

Q34661581-C8E81EC9-1468-4F24-9E27-6E985B8A291B

Q34661581-C9906F7D-5294-4044-9DC0-94790D73AD26

P2860

Q34661581-04A1DBD3-5CDE-4266-A825-8A5255E9A3BA

Q34661581-08BC696A-85AF-4AA3-A4ED-AC73BD7D88BC

Q34661581-08D645DE-8CCD-4A22-A6C1-D7547C3E3B4F

Q34661581-1158C1B1-6A36-467D-9CCA-EB0C8DD2CB5D

Q34661581-140B6BB0-98F6-4A4E-8EF5-97CB030C3158

Q34661581-143DD7B7-C9E4-465C-863F-CAEB169EC6F5

Q34661581-1686EF9A-5E41-4867-ADD1-C46DDC7EE7F2

Q34661581-19FBC758-1C28-4A27-84F0-2C4272BE062B

Q34661581-1C1161A4-93B9-4BCB-9721-B3CF4FE081C7

Q34661581-28AC4DB6-20B5-4B1F-8C04-8FFF6DFD8333

P2888

Q34661581-755D29FA-7314-4DED-B1DA-8E6F3000C4E8

P304

Q34661581-B0AE81E5-9372-4C08-A332-235158954DF7

P31

Q34661581-EECF3C39-5F3A-46B7-B00C-7234FE51DB09

P356

Q34661581-0EDDC8FB-5AC2-4C7B-B4B2-42586C84B787

P407

Q34661581-AD6361FE-1ABD-44BE-9F1C-8A3C3F6ED602

P433

Q34661581-2C2497F1-3873-4159-B9C0-B6228DEA6FF6

P478

Q34661581-D1B34C95-4A00-4476-8D99-3899111FA053

P50

Q34661581-AEF2134A-B01F-4EE7-911E-C288961C903A

P577

Q34661581-8250036A-714B-4FDB-B0E6-0CACAA9922C8

P5875

Q34661581-FDEA49C8-16EA-4FCB-BA27-66249DDEB95F

P6179

Q34661581-30319906-4938-4FD4-9701-9ACD7A8D12EB

P698

Q34661581-4BB774AE-4D4D-4A93-ADC7-56E44AF06EDF

P932

Q34661581-2F2AE1FC-43AE-4105-A8BB-215291F9A021

P356

P1433

Neuropsychopharmacology

P1476

Rapid enhancement of glutamate ...... lowing treatment with riluzole

@en

P2093

Andrew P Prescot

http://www.w3.org/2001/XMLSchema#string

Brian P Brennan

http://www.w3.org/2001/XMLSchema#string

Bruce M Cohen

http://www.w3.org/2001/XMLSchema#string

Dost Ongür

http://www.w3.org/2001/XMLSchema#string

Harrison G Pope

http://www.w3.org/2001/XMLSchema#string

J Eric Jensen

http://www.w3.org/2001/XMLSchema#string

Jacqueline L Roberts

http://www.w3.org/2001/XMLSchema#string

James I Hudson

http://www.w3.org/2001/XMLSchema#string

Julie McCarthy

http://www.w3.org/2001/XMLSchema#string

P2860

Acute mania is accompanied by elevated glutamate/glutamine levels within the left dorsolateral prefrontal cortex

Ampakines cause sustained increases in brain-derived neurotrophic factor signaling at excitatory synapses without changes in AMPA receptor subunit expression

Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder

AMPA protects cultured neurons against glutamate excitotoxicity through a phosphatidylinositol 3-kinase-dependent activation in extracellular signal-regulated kinase to upregulate BDNF gene expression

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

In vivo NMR studies of the glutamate neurotransmitter flux and neuroenergetics: implications for brain function.

Clinical studies implementing glutamate neurotransmission in mood disorders.

Omega-3 fatty acid treatment and T(2) whole brain relaxation times in bipolar disorder.

Beyond monoamines: glutamatergic function in mood disorders.

N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.

P2888

P304

834-846

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NPP.2009.191

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

Perry F Renshaw

P577

2009-12-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40443218

http://www.w3.org/2001/XMLSchema#string

P6179

1035331928

http://www.w3.org/2001/XMLSchema#string

P698

19956089

http://www.w3.org/2001/XMLSchema#string

P932

3055603

http://www.w3.org/2001/XMLSchema#string